Company
Headquarters: Elk City, ID, United States
Employees: 3
CEO: Mr. Timothy George Dixon
$4.9 Million
USD as of Jan. 1, 2024
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, improve maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship products include NanoStilbene, an easily absorbed nanoemulsion of nanoparticle pterostilbene to reduce inflammatory cytokine production in cancer patients; and ProJuvenol, a synergistic blend of complex anti-aging ingredients. The company also focuses on the manufacture of devices to treat patients with obstructive sleep apnea. Therapeutic Solutions International, Inc. is based in Elk City, Idaho.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Therapeutic Solutions International, Inc. has the following listings and related stock indices.
Stock: OTC: TSOI wb_incandescent